Crossmark

Resource use and healthcare costs in patients with overactive bladder who initiate treatment with mirabegron or antimuscarinic monotherapy in Catalonia: the MIRACAT study

Crossref DOI link: https://doi.org/10.1016/j.acuroe.2021.12.007

Published Print: 2022-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Martins de Almeida, R.

Mateu Arrom, L.

Ortíz Núñez, A.

Covernton, P.J.O.

Mora Blazquez, A.M.
License Information

Text and Data Mining valid from 2022-04-01
More Information

This article is maintained by: Elsevier

Article Title: Resource use and healthcare costs in patients with overactive bladder who initiate treatment with mirabegron or antimuscarinic monotherapy in Catalonia: the MIRACAT study

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2021.12.007

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2021.12.003

Content Type: article

Copyright: © 2022 AEU. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below